Grape King Bio Ltd Total Liabilities
Grape King Bio Ltd total liabilities. Based on the latest financial reports, Grape King Bio Ltd (1707) has total liabilities worth NT$3.40 Billion TWD (≈ $107.07 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 1707 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Grape King Bio Ltd (2002–2025)
Total liabilities of Grape King Bio Ltd from 2002 to 2025. This chart illustrates how Grape King Bio Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Grape King Bio Ltd (1707) investment intensity to see how much of total assets are deployed in long-term investments.
Grape King Bio Ltd Competitors by Total Liabilities
The table below lists competitors of Grape King Bio Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
USA | $85.96 Million |
|
Lets Holding Group Co Ltd
SHE:002398
|
China | CN¥2.12 Billion |
|
Thonburi Healthcare Grp Pcl
BK:THG
|
Thailand | ฿5.92 Billion |
|
Alexander Marine Co Ltd
TW:8478
|
Taiwan | NT$6.86 Billion |
|
YoungPoong
KO:000670
|
Korea | ₩1.91 Trillion |
|
Oxford Industries Inc
NYSE:OXM
|
USA | $734.78 Million |
|
Lux Industries Limited
NSE:LUXIND
|
India | Rs-18.21 Billion |
|
Shandong Xinjufeng Technology Packaging Co. Ltd. A
SHE:301296
|
China | CN¥3.38 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Grape King Bio Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Grape King Bio Ltd balance sheet assets.
Liquidity & Leverage Metrics
Grape King Bio Ltd Total Liabilities Ratios Explained
Grape King Bio Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Grape King Bio Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Grape King Bio Ltd (2002–2025)
The table below shows the annual total liabilities of Grape King Bio Ltd from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$3.67 Billion ≈ $115.69 Million |
+3.93% |
| 2024-12-31 | NT$3.53 Billion ≈ $111.31 Million |
-8.99% |
| 2023-12-31 | NT$3.88 Billion ≈ $122.30 Million |
-0.77% |
| 2022-12-31 | NT$3.91 Billion ≈ $123.25 Million |
+7.72% |
| 2021-12-31 | NT$3.63 Billion ≈ $114.41 Million |
-29.15% |
| 2020-12-31 | NT$5.13 Billion ≈ $161.49 Million |
+31.83% |
| 2019-12-31 | NT$3.89 Billion ≈ $122.50 Million |
+4.67% |
| 2018-12-31 | NT$3.71 Billion ≈ $117.04 Million |
+4.24% |
| 2017-12-31 | NT$3.56 Billion ≈ $112.28 Million |
-5.39% |
| 2016-12-31 | NT$3.77 Billion ≈ $118.68 Million |
-14.25% |
| 2015-12-31 | NT$4.39 Billion ≈ $138.40 Million |
+165.89% |
| 2014-12-31 | NT$1.65 Billion ≈ $52.05 Million |
+17.33% |
| 2013-12-31 | NT$1.41 Billion ≈ $44.36 Million |
+25.02% |
| 2012-12-31 | NT$1.13 Billion ≈ $35.48 Million |
+14.41% |
| 2011-12-31 | NT$984.40 Million ≈ $31.01 Million |
+4.58% |
| 2010-12-31 | NT$941.33 Million ≈ $29.66 Million |
-16.64% |
| 2009-12-31 | NT$1.13 Billion ≈ $35.58 Million |
+34.18% |
| 2008-12-31 | NT$841.61 Million ≈ $26.52 Million |
+11.77% |
| 2007-12-31 | NT$753.00 Million ≈ $23.72 Million |
-4.18% |
| 2006-12-31 | NT$785.85 Million ≈ $24.76 Million |
+2.32% |
| 2005-12-31 | NT$768.01 Million ≈ $24.20 Million |
-12.30% |
| 2004-12-31 | NT$875.75 Million ≈ $27.59 Million |
+5.97% |
| 2003-12-31 | NT$826.42 Million ≈ $26.04 Million |
-19.09% |
| 2002-12-31 | NT$1.02 Billion ≈ $32.18 Million |
-- |
About Grape King Bio Ltd
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; a… Read more